Literature DB >> 27002532

Does the Microbiome Cause B27-related Acute Anterior Uveitis?

James T Rosenbaum1,2,3, Phoebe Lin2, Mark Asquith3.   

Abstract

The microbiome is strongly implicated in a broad spectrum of immune-mediated diseases. Data support the concept that HLA molecules shape the microbiome. We provide hypotheses to reconcile how HLA-B27 might affect the microbiome and in turn predispose to acute anterior uveitis. These theories include bacterial translocation, antigenic mimicry, and dysbiosis leading to alterations in regulatory and effector T-cell subsets. Received 31 October 2015; revised 7 January 2016; accepted 8 January 2016; published online 22 March 2016.

Entities:  

Keywords:  Ankylosing spondylitis; HLA-B27; microbiome; spondyloarthropathy; uveitis

Mesh:

Substances:

Year:  2016        PMID: 27002532      PMCID: PMC4988830          DOI: 10.3109/09273948.2016.1142574

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  44 in total

1.  MUCOSAL IMMUNOLOGY. Individual intestinal symbionts induce a distinct population of RORγ⁺ regulatory T cells.

Authors:  Esen Sefik; Naama Geva-Zatorsky; Sungwhan Oh; Liza Konnikova; David Zemmour; Abigail Manson McGuire; Dalia Burzyn; Adriana Ortiz-Lopez; Mercedes Lobera; Jianfei Yang; Shomir Ghosh; Ashlee Earl; Scott B Snapper; Ray Jupp; Dennis Kasper; Diane Mathis; Christophe Benoist
Journal:  Science       Date:  2015-08-13       Impact factor: 47.728

2.  Acute anterior uveitis and HL-A 27.

Authors:  D A Brewerton; M Caffrey; A Nicholls; D Walters; D C James
Journal:  Lancet       Date:  1973-11-03       Impact factor: 79.321

3.  The role of HLA-B27 in spondyloarthritis.

Authors:  Joel D Taurog
Journal:  J Rheumatol       Date:  2010-12       Impact factor: 4.666

4.  Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota.

Authors:  June L Round; Sarkis K Mazmanian
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-21       Impact factor: 11.205

5.  Salmonella lipopolysaccharide in synovial cells from patients with reactive arthritis.

Authors:  K Granfors; S Jalkanen; A A Lindberg; O Mäki-Ikola; R von Essen; R Lahesmaa-Rantala; H Isomäki; R Saario; W J Arnold; A Toivanen
Journal:  Lancet       Date:  1990-03-24       Impact factor: 79.321

6.  The HLA-DQ2 genotype selects for early intestinal microbiota composition in infants at high risk of developing coeliac disease.

Authors:  M Olivares; A Neef; G Castillejo; G De Palma; V Varea; A Capilla; F Palau; E Nova; A Marcos; I Polanco; C Ribes-Koninckx; L Ortigosa; L Izquierdo; Y Sanz
Journal:  Gut       Date:  2014-06-17       Impact factor: 23.059

7.  Intestinal permeability in patients with ankylosing spondylitis and their healthy relatives.

Authors:  O Martínez-González; J Cantero-Hinojosa; P Paule-Sastre; J C Gómez-Magán; D Salvatierra-Ríos
Journal:  Br J Rheumatol       Date:  1994-07

8.  Bacterial antigens in synovial biopsy specimens in yersinia triggered reactive arthritis.

Authors:  R Merilahti-Palo; K O Söderström; R Lahesmaa-Rantala; K Granfors; A Toivanen
Journal:  Ann Rheum Dis       Date:  1991-02       Impact factor: 19.103

9.  Genetic dissection of acute anterior uveitis reveals similarities and differences in associations observed with ankylosing spondylitis.

Authors:  Philip C Robinson; Theodora A M Claushuis; Adrian Cortes; Tammy M Martin; David M Evans; Paul Leo; Pamela Mukhopadhyay; Linda A Bradbury; Katie Cremin; Jessica Harris; Walter P Maksymowych; Robert D Inman; Proton Rahman; Nigil Haroon; Lianne Gensler; Joseph E Powell; Irene E van der Horst-Bruinsma; Alex W Hewitt; Jamie E Craig; Lyndell L Lim; Denis Wakefield; Peter McCluskey; Valentina Voigt; Peter Fleming; Mariapia Degli-Esposti; Jennifer J Pointon; Michael H Weisman; B Paul Wordsworth; John D Reveille; James T Rosenbaum; Matthew A Brown
Journal:  Arthritis Rheumatol       Date:  2015-01       Impact factor: 10.995

10.  The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats.

Authors:  J D Taurog; J A Richardson; J T Croft; W A Simmons; M Zhou; J L Fernández-Sueiro; E Balish; R E Hammer
Journal:  J Exp Med       Date:  1994-12-01       Impact factor: 14.307

View more
  8 in total

Review 1.  Uveitis and the gut microbiota.

Authors:  Shilpa Kodati; H Nida Sen
Journal:  Best Pract Res Clin Rheumatol       Date:  2020-04-09       Impact factor: 4.098

Review 2.  The microbiome and ophthalmic disease.

Authors:  Adam D Baim; Asadolah Movahedan; Asim V Farooq; Dimitra Skondra
Journal:  Exp Biol Med (Maywood)       Date:  2018-11-21

Review 3.  Microbiome in Immune-Mediated Uveitis.

Authors:  Carmen Antía Rodríguez-Fernández; Manuel Busto Iglesias; Begoña de Domingo; Kelly Conde-Pérez; Juan A Vallejo; Lorena Rodríguez-Martínez; Miguel González-Barcia; Victor Llorenç; Cristina Mondelo-Garcia; Margarita Poza; Anxo Fernández-Ferreiro
Journal:  Int J Mol Sci       Date:  2022-06-24       Impact factor: 6.208

Review 4.  Inpatient Ophthalmology Consultations.

Authors:  Dilraj S Grewal; Hesham Gabr
Journal:  Med Clin North Am       Date:  2021-04-02       Impact factor: 5.456

Review 5.  A Possible Role of Intestinal Microbiota in the Pathogenesis of Ankylosing Spondylitis.

Authors:  Lianjun Yang; Liping Wang; Xin Wang; Cory J Xian; Hai Lu
Journal:  Int J Mol Sci       Date:  2016-12-17       Impact factor: 5.923

6.  Alterations in the Ocular Surface Fungal Microbiome in Fungal Keratitis Patients.

Authors:  Gumpili Sai Prashanthi; Rajagopalaboopathi Jayasudha; Sama Kalyana Chakravarthy; Shalem Raj Padakandla; Chinthala Reddy SaiAbhilash; Savitri Sharma; Bhupesh Bagga; Somasheila I Murthy; Prashant Garg; Sisinthy Shivaji
Journal:  Microorganisms       Date:  2019-09-02

Review 7.  Recent Developments in HLA B27 Anterior Uveitis.

Authors:  Denis Wakefield; Daniel Clarke; Peter McCluskey
Journal:  Front Immunol       Date:  2021-01-05       Impact factor: 7.561

8.  Ocular Microbiota and Intraocular Inflammation.

Authors:  Jing Jing Li; Sanjun Yi; Lai Wei
Journal:  Front Immunol       Date:  2020-12-23       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.